Abstract:Parkinson’s disease (PD) is a progressive neurodegenerative disorder characterized by bradykinesia, rigidity, and tremor. Considerable progress has been made to understand the exact mechanism leading to this disease. Most of what is known comes from the evidence of PD brains’ autopsies showing a deposition of Lewy bodies—containing a protein called α-synuclein (α-syn)—as the pathological determinant of PD. α-syn predisposes neurons to neurotoxicity and cell death, while the other associated mechanisms are mitochondrial dysfunction and oxidative stress, which are underlying precursors to the death of dopaminergic neurons at the substantia nigra pars compacta leading to disease progression. Several mechanisms have been proposed to unravel the pathological cascade of these diseases; most of them share a particular similarity: cell-to-cell communication through exosomes (EXOs). EXOs are intracellular membrane-based vesicles with diverse compositions involved in biological and pathological processes, which their secretion is driven by the NLR family pyrin domain-containing three proteins (NLRP3) inflammasome. Toxic biological fibrils are transferred to recipient cells, and the disposal of damaged organelles through generating mitochondrial-derived vesicles are suggested mechanisms for developing PD. EXOs carry various biomarkers; thus, they are promising to diagnose different neurological disorders, including neurodegenerative diseases (NDDs). As nanovesicles, the applications of EXOs are not only restricted as diagnostics but also expanded to treat NDDs as therapeutic carriers and nano-scavengers. Herein, the aim is to highlight the potential incrimination of EXOs in the pathological cascade and progression of PD and their role as biomarkers and therapeutic carriers for diagnosing and treating this neuro-debilitating disorder.

Impact of endolysosomal dysfunction upon exosomes in neurodegenerative diseases

Endolysosomal dysfunction and exosome secretion: implications for neurodegenerative disorders

Endo-lysosomal dysfunction in neurodegenerative diseases: opinion on current progress and future direction in the use of exosomes as biomarkers

Role of Exosomes in the Pathogenesis and Theranostic of Alzheimer's Disease and Parkinson's Disease

Contribution of Autophagy-Lysosomal Pathway in the Exosomal Secretion of Alpha-Synuclein and Its Impact in the Progression of Parkinson’s Disease

Shared and distinct changes in the molecular cargo of extracellular vesicles in different neurodegenerative diseases

The interplay between aging-associated loss of protein homeostasis and extracellular vesicles in neurodegeneration

Microglial Exosomes in Neurodegenerative Disease

Exosomes in Parkinson: Revisiting Their Pathologic Role and Potential Applications

Exosomes, an Unmasked Culprit in Neurodegenerative Diseases

Endosomal dysfunction impacts extracellular vesicle release: Central role in Aβ pathology

Role of exosomes in the pathogenesis, diagnosis, and treatment of central nervous system diseases

Diagnostic and Therapeutic Potential of Exosomes in Neurodegenerative Diseases

The role of exosomes in the pathogenesis of Alzheimer’ disease

[Roles of Exosomes in Parkinson's Disease and Amyotrophic Lateral Sclerosis].

Focus on Extracellular Vesicles: Exosomes and Their Role in Protein Trafficking and Biomarker Potential in Alzheimer’s and Parkinson’s Disease

Role of extracellular vesicles in neurodegenerative diseases

Dual Role of Exosome in Neurodegenerative Diseases: A Review Study

Emerging Roles of Extracelluar Vesicles Derived from Bacteria, Mammalian or Plant Cells in the Pathogenesis and Clinical Application of Neurodegenerative Diseases

The Evolving Landscape of Exosomes in Neurodegenerative Diseases: Exosomes Characteristics and a Promising Role in Early Diagnosis

Dysfunctional Autophagy and Endolysosomal System in Neurodegenerative Diseases: Relevance and Therapeutic Options